Aino Health AB (publ) (FRA:50V)

Aino Health AB Income Statement

Financials in millions SEK. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Operating Revenue	26.11	23.94	23.92	19.91	23.04
Revenue	26.11	23.94	23.92	19.91	23.04
Revenue Growth (YoY)	9.07%	0.09%	20.15%	-13.61%	-9.40%
Cost of Revenue	18.36	19.78	20.12	20.5	21.34
Gross Profit	7.75	4.16	3.8	-0.59	1.7
Selling, General & Admin	10.07	10.33	10.14	10.89	13.08
Other Operating Expenses	0.02	0.09	1.33	0.2	0.06
Operating Expenses	13.01	13.41	14.46	13.97	15.93
Operating Income	-5.26	-9.25	-10.67	-14.56	-14.23
Interest Expense	-0.86	-	-	-	-1.3
Interest & Investment Income	-	0	0	-	0.26
Currency Exchange Gain (Loss)	-	0.12	1.1	0.39	0.06
Other Non Operating Income (Expenses)	0.01	-0.79	-1.1	-0.8	-
Pretax Income	-6.11	-9.92	-10.66	-14.96	-15.22
Net Income	-6.11	-9.92	-10.66	-14.96	-15.22
Net Income to Common	-6.11	-9.92	-10.66	-14.96	-15.22
Shares Outstanding (Basic)	205	99	55	41	25
Shares Outstanding (Diluted)	205	99	55	41	25
Shares Change (YoY)	106.32%	80.83%	33.82%	61.53%	34.87%
EPS (Basic)	-0.03	-0.10	-0.19	-0.37	-0.60
EPS (Diluted)	-0.03	-0.10	-0.19	-0.37	-0.60
Free Cash Flow	-2.41	-4.55	-6.26	-12.87	-8.11
Free Cash Flow Per Share	-0.01	-0.05	-0.11	-0.31	-0.32
Gross Margin	29.67%	17.37%	15.88%	-2.97%	7.38%
Operating Margin	-20.13%	-38.64%	-44.59%	-73.12%	-61.76%
Profit Margin	-23.40%	-41.42%	-44.57%	-75.16%	-66.05%
Free Cash Flow Margin	-9.24%	-19.00%	-26.18%	-64.66%	-35.21%
EBITDA	-2.35	-7.23	-8.63	-12.65	-12.4
EBITDA Margin	-8.99%	-30.18%	-36.08%	-63.52%	-53.81%
D&A For EBITDA	2.91	2.03	2.04	1.91	1.83
EBIT	-5.26	-9.25	-10.67	-14.56	-14.23
EBIT Margin	-20.13%	-38.64%	-44.59%	-73.12%	-61.76%
Revenue as Reported	-	23.99	25.07	20.05	23.1

Source: S&P Global Market Intelligence. Standard template. Financial Sources.